We congratulate the U.S. Preventative Task Force on its recent recommendation
in regards to prostate cancer screening in young healthy males. We recognize the
Herculean task put before the members of the task force, and applaud them for
bringing this controversial topic to the forefront of public discussion.
However we are concerned that their recommendations to advise against
routine screening may be misguided and misinterpreted. Their final conclusion
was based on reviewing previous scientific trials - that even they admitted were
fraught with contamination and potential biases. In their concluding sentences,
they even mention that these studies had not reached maturity and that over the
next decade, as these studies mature, they will give a clearer picture as to the
potential benefit of prostate cancer screening.
We are concerned that lost in this report is that approximately 32,000
American men will die of prostate cancer this year, and that prostate cancer is
the second leading cause of cancer death in American men. We are also concerned
that this report did not sufficiently take into account what benefit prostate
cancer screening and early detection may have on decreasing or preventing the
debilitating effects of advanced or metastatic prostate cancer. In countries
where little prostate cancer screening is done, half of the men diagnosed with
prostate cancer die from their cancer. Since the introduction of Prostatic
Specific Antigen (P.S.A.), a blood test used for prostate cancer screening, the
incidence of death from prostate cancer has declined with no other clear cause,
and the task force trial did not address this fact.
We do agree with the task force that not all men need to be screened for
prostate cancer, and that certain men with prostate cancer should be observed
and not treated - initially or perhaps ever. We also agree with their unstated
belief that we as a medical community, as a whole, need to continue to research
and refine our diagnosis and treatments to improve the health outcomes of our
patients and minimize any potential side effects to our treatments.
Eliminating prostate cancer screening will not eliminate disease. The
urologist at Atlantic Urological Associates feel strongly that if you are
concerned or at risk for prostate cancer, you should consult your urologist to
discuss whether prostate cancer screening is in your best interest.
Regan is a urologist in Palm Coast and the president of the Florida
Urological Society
Brown elected President of the Board for the American
Association of Clinical Urologists
Atlantic Urological Associates is pleased to announce
that B. Thomas Brown, M.D, M.B.A., F.A.C.S., has been elected President of the
Board of Directors for the American
Association of Clinical Urologists. This
is a distinctive honor for Dr. Brown, and one of many noteworthy accomplishments
he has achieved throughout his medical career."Forty-five percent of all urologists nationwide
are members of the AACU. It is an honor to follow the previous presidents and to
serve my
colleagues in this capacity", Brown said. The
AACU is the only national organization to serve urology with sole purpose of
promoting and preserving the professional autonomy and
financial viability of each of its members. AACU's resources are
dedicated to inform members of the issues affecting their
practice and profession, and then to work directly to influence the resolutions
of these issues.
Dr. Brown completed his premedical education at The
Johns Hopkins University and received his medical degree from West Virginia
University.He completed his residency in urology at the University of Miami, and
began private practice in the Daytona Beach area in 1978. He has an MBA
from the University of South Florida.
Dr. Brown is certified by the American Board of Urology, and is a
Fellow in the American College of Surgeons. He is very active within the
specialty of Urology, and has held various professional appointments throughout
his career. Dr. Brown is a former President of the Southeastern Section of the
American Urological Association, is currently a member of the Board of Directors
of the American Urological Association, has served as Chairman of the Committee
on Applicants for the American College of Surgeons, and is a Past Chairman for
the Department of Urology at both Halifax Medical Center and Memorial Hospital.
Dr. Brown also serves as a Charter Coordinator for the Organ Donor Program at
Halifax Medical Center.
Grable and Regan Elected to Top Offices for the Florida
Urological Society
Atlantic Urological Associates announced today that two members of
the practice, Michael S. Grable, M.D., F.A.C.S., and Terrence C. Regan, M.D.
were elected President and President-Elect of the Florida Urological Society, at
the 62nd Annual Meeting in Orlando, Florida. This is a distinctive honor for
both Dr. Grable and Dr. Regan.
The Florida Urological Society's primary mission is to provide an
educational, political, social and economic advisory forum, as well as a common
voice for all urologists in the State of Florida. As President and
President-Elect of the Florida Urological Society, Dr. Grable and Dr. Regan will
assist with planning for the 2011 annual meeting.
Dr. Grable received his Bachelor's degree at the University of
Michigan, and his medical degree at the University of Michigan Medical School.
He completed his residency training at the University of Florida School of
Medicine. He is certified by the American Board of Urology and is a fellow of
the American College of Surgeons. He is a member of the American Urological
Association and the American Medical Association.
Dr. Regan completed a Bachelor of Arts degree from Notre Dame, and
received his medical degree from Georgetown University Medical School. He
completed his residency training in Urology at Georgetown University. Dr. Regan
is certified by the American Board of Urology. He is a member of the American
Urological Association, the Southeaster Section of the American Urological
Association, the Florida Medical Association and the Volusia County Medical
Society.
Dr. Grable is the acting President/CEO of Atlantic Urological
Associates, a 13 provider Urology group with offices located throughout Volusia,
Flagler and St. John's counties. The group specializes in the diagnosis and
treatment of male and female urological conditions including, prostate cancer,
urinary incontinence, erectile dysfunction, and kidney stones. Atlantic
Urological Associates' commitment to leading edge urology and patient-centered
care, builds on the groups' reputation as the provider of premier Urologic
care in East Central Florida.
Dr. Dineen and Tom Sellers featured in Urology Times
Dr. Dineen and Tom Sellers, Director of AUA's Male Sexual Dysfunction Clinic, were recently featured in Urology Times for their work on the use of Implant protocol to reduce penile shortening...click on the link below to read article...
Urology Times
Dr. Brown Now in our Port Orange Office
Dr. Brown is now seeing patients in Atlantic Urological's Port Orange office. If you are in the Port Orange area and need consultation, you may reach us by phone at (386) 756-1118. If you'd like to stop in and visit with us, we are located at 633 Dunlawton Ave, Suite 2 between S Ridgewood Ave and Nova Rd.
Dr. Brown has held various professional appointments throughout his career. He is a former President of the Southeastern Section of the American Urological Association. He has served as Chairman of the Committee on Applicants for the American College of Surgeons, and is a Past Chairman for the Department of Urology at both Halifax Medical Center and Memorial Hospital. Dr. Brown also serves as a Charter Coordinator for the Organ Donor Program at Halifax Medical Center.
We at Atlantic Urological look forward to seeing you in our Port Orange office.
Atlantic Urological Associates Receives National Recognition
Michael S. Grable, MD, FACS, President and CEO of Atlantic Urological Associates announced that Atlantic Urological Associates will be featured in the Medical Group Management Association’s new Performance and Practices of Successful Medical Groups 2007 Report. “This is a significant achievement for our practice to be recognized at the national level, and echoes our commitment to be the premier provider of Urologic care in Central Florida” Grable said.
This is the second consecutive year that Atlantic Urological Associates has received this honor, making it the only private medical practice in the Volusia-Flagler area, and one of the few medical practices in the state to achieve this honor.
The Medical Group Management Association (MGMA) is the nation’s principal voice for medical group practices. Each year, MGMA compares the performance of medical groups based on profitability and cost management, productivity and capacity of staffing, accounts receivable and collections, and patient satisfaction. The MGMA report found that compared with “other” medical group practices, “better-performers” are more likely to:
- Have already invested in Information Technology
- Have conducted more medical procedures per year than their counterparts
- Have better collection percentages and substantially lower levels of bad debt.
Atlantic Urological Associates is comprised of 12 Urologists serving Volusia, Flagler and St. John’s counties, with 8 office locations. The practice specializes in the diagnosis, care and treatment of disease of the male and female urinary tract and male reproductive system, including prostate, urinary incontinence, erectile dysfunction, vasectomy, kidney stones and cancer. The practice actively participates in research and clinical studies, and offers state-of-the art methods of diagnosis and treatment to patients.
Dineen Named President of the
Southeastern Section of the American Urological Association
Martin K. Dineen, M. D. has been named President to the Board of Directors of the Southeastern Section of the American Urological Association for the 2008-2009 term. This appointment is a distinctive honor for Dr. Dineen, and Atlantic Urological Associates.
The Southeastern Section is composed of almost 2,100 urologists; all the active members having been certified by the American Board of Urology, practicing, teaching, and researching in 9 of the southeastern United States, Panama, Puerto Rico, and the U.S. Virgin Islands. Numerically, this is the largest of all the sections of the AUA.
Daytona Beach Office Receives City’s Beautification Award
The physicians and staff of our Daytona Beach Office were delighted to receive the Daytona Beach Commercial Beautification Award, presented by Mayor Glenn Ritchey. This is the second time the office has been awarded this honor. A slide show depicting the property’s landscaping, highlighting various plants, trees and shrubs that are native to Florida, was presented during the City Council Meeting.
